Annual Cash & Cash Equivalents
$35.08 M
-$20.93 M-37.37%
31 December 2023
Summary:
Lumos Pharma annual cash & cash equivalents is currently $35.08 million, with the most recent change of -$20.93 million (-37.37%) on 31 December 2023. During the last 3 years, it has fallen by -$59.73 million (-63.00%).LUMO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$13.52 M
-$3.28 M-19.52%
30 September 2024
Summary:
Lumos Pharma quarterly cash and cash equivalents is currently $13.52 million, with the most recent change of -$3.28 million (-19.52%) on 30 September 2024. Over the past year, it has dropped by -$21.56 million (-61.46%).LUMO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LUMO Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -61.5% |
| 3 y3 years | -63.0% | -85.7% |
| 5 y5 years | +608.4% | +173.0% |
LUMO Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -82.1% | -93.5% |
Lumos Pharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $13.52 M(-19.5%) |
| June 2024 | - | $16.80 M(-27.5%) |
| Mar 2024 | - | $23.18 M(-33.9%) |
| Dec 2023 | $35.08 M(-37.4%) | $35.08 M(-1.3%) |
| Sept 2023 | - | $35.56 M(-6.1%) |
| June 2023 | - | $37.86 M(-14.0%) |
| Mar 2023 | - | $44.04 M(-21.4%) |
| Dec 2022 | $56.01 M(-40.9%) | $56.01 M(-24.0%) |
| Sept 2022 | - | $73.67 M(-7.4%) |
| June 2022 | - | $79.51 M(-8.4%) |
| Mar 2022 | - | $86.76 M(-8.5%) |
| Dec 2021 | $94.81 M(-3.9%) | $94.81 M(-5.8%) |
| Sept 2021 | - | $100.65 M(-6.5%) |
| June 2021 | - | $107.70 M(-5.6%) |
| Mar 2021 | - | $114.10 M(+15.6%) |
| Dec 2020 | $98.68 M(+1892.7%) | $98.68 M(-6.5%) |
| Sept 2020 | - | $105.58 M(+45.2%) |
| June 2020 | - | $72.70 M(-15.3%) |
| Mar 2020 | - | $85.82 M(+1633.1%) |
| Dec 2019 | $4.95 M(-95.9%) | $4.95 M(-95.0%) |
| Sept 2019 | - | $98.53 M(-6.5%) |
| June 2019 | - | $105.37 M(-6.9%) |
| Mar 2019 | - | $113.18 M(-6.3%) |
| Dec 2018 | $120.74 M(-23.9%) | $120.74 M(-1.1%) |
| Sept 2018 | - | $122.06 M(-10.9%) |
| June 2018 | - | $137.07 M(-4.7%) |
| Mar 2018 | - | $143.89 M(-9.3%) |
| Dec 2017 | $158.71 M | $158.71 M(+31.5%) |
| Sept 2017 | - | $120.70 M(+12.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2017 | - | $107.78 M(-8.8%) |
| Mar 2017 | - | $118.24 M(-10.1%) |
| Dec 2016 | $131.49 M(-32.8%) | $131.49 M(-11.3%) |
| Sept 2016 | - | $148.28 M(-7.6%) |
| June 2016 | - | $160.53 M(-9.3%) |
| Mar 2016 | - | $176.99 M(-9.5%) |
| Dec 2015 | $195.62 M(+2.7%) | $195.62 M(-0.8%) |
| Sept 2015 | - | $197.14 M(-3.1%) |
| June 2015 | - | $203.38 M(-1.6%) |
| Mar 2015 | - | $206.59 M(+8.5%) |
| Dec 2014 | $190.40 M(+210.7%) | $190.40 M(+272.8%) |
| Sept 2014 | - | $51.07 M(-33.6%) |
| June 2014 | - | $76.86 M(-8.2%) |
| Mar 2014 | - | $83.71 M(+36.6%) |
| Dec 2013 | $61.29 M(+202.7%) | $61.29 M(+17.9%) |
| Sept 2013 | - | $51.96 M(-12.0%) |
| June 2013 | - | $59.04 M(-6.7%) |
| Mar 2013 | - | $63.28 M(+212.5%) |
| Dec 2012 | $20.25 M(-48.7%) | $20.25 M(-20.8%) |
| Sept 2012 | - | $25.56 M(-15.7%) |
| June 2012 | - | $30.33 M(-8.8%) |
| Mar 2012 | - | $33.27 M(-15.8%) |
| Dec 2011 | $39.49 M(+273.5%) | $39.49 M(+528.1%) |
| Sept 2011 | - | $6.29 M(-34.2%) |
| June 2011 | - | $9.55 M(-9.7%) |
| Dec 2010 | $10.57 M(-30.5%) | $10.57 M(+82.0%) |
| Sept 2010 | - | $5.81 M(-61.8%) |
| Dec 2009 | $15.22 M(+142.5%) | $15.22 M |
| Dec 2008 | $6.28 M | - |
FAQ
- What is Lumos Pharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Lumos Pharma?
- What is Lumos Pharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Lumos Pharma?
- What is Lumos Pharma quarterly cash and cash equivalents year-on-year change?
What is Lumos Pharma annual cash & cash equivalents?
The current annual cash & cash equivalents of LUMO is $35.08 M
What is the all time high annual cash & cash equivalents for Lumos Pharma?
Lumos Pharma all-time high annual cash & cash equivalents is $195.62 M
What is Lumos Pharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of LUMO is $13.52 M
What is the all time high quarterly cash and cash equivalents for Lumos Pharma?
Lumos Pharma all-time high quarterly cash and cash equivalents is $206.59 M
What is Lumos Pharma quarterly cash and cash equivalents year-on-year change?
Over the past year, LUMO quarterly cash and cash equivalents has changed by -$21.56 M (-61.46%)